Search

Search Constraints

You searched for: Author/Creator Anglesio, Michael S

Search Results

1. Oncogenic mutations in histologically normal endometrium: the new normal?. Issue 2 (22nd July 2019)

4. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas. Issue 4 (7th February 2022)

5. 2022-RA-894-ESGO Endometrioid ovarian carcinoma – real world evidence from a large transatlantic team initiative: First results of the LEOPARD study. (20th October 2022)

8. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. Issue 2 (23rd March 2015)

9. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis. Issue 2 (6th July 2015)

10. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. Issue 1 (17th December 2012)